Drug interactions for the following drug(s)
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Magnesium Oxide 400 MG Oral Tablet
Magnesium oxide can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> valACYclovir 1 GM Oral Tablet
Valaciclovir may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> Depakote 125 MG Delayed Release Oral Tablet
The metabolism of Metoprolol can be decreased when combined with Valproic acid.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
The risk or severity of adverse effects can be increased when Metoprolol is combined with Caffeine.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> atorvastatin 20 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Acetaminophen.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Depakote 125 MG Delayed Release Oral Tablet
The metabolism of Valproic acid can be decreased when combined with Acetylsalicylic acid.
Applies to: Magnesium Oxide 400 MG Oral Tablet <> Levothyroxine Sodium 0.15 MG Oral Tablet
Magnesium oxide can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: Levothyroxine Sodium 0.15 MG Oral Tablet <> atorvastatin 20 MG Oral Tablet
The metabolism of Levothyroxine can be decreased when combined with Atorvastatin.
Applies to: Depakote 125 MG Delayed Release Oral Tablet <> atorvastatin 20 MG Oral Tablet
The metabolism of Atorvastatin can be decreased when combined with Valproic acid.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> Levothyroxine Sodium 0.15 MG Oral Tablet
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Metoprolol.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> valACYclovir 1 GM Oral Tablet
Valaciclovir may decrease the excretion rate of Metoprolol which could result in a higher serum level.
Applies to: Depakote 125 MG Delayed Release Oral Tablet <> valACYclovir 1 GM Oral Tablet
The excretion of Valaciclovir can be decreased when combined with Valproic acid.
Applies to: Levothyroxine Sodium 0.15 MG Oral Tablet <> Depakote 125 MG Delayed Release Oral Tablet
The metabolism of Levothyroxine can be decreased when combined with Valproic acid.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Levothyroxine Sodium 0.15 MG Oral Tablet
Levothyroxine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Magnesium Oxide 400 MG Oral Tablet
Drug1 (rxcui = 209468, name = acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin], tty = SBD). Drug2 (rxcui = 198741, name = magnesium oxide 400 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to magnesium oxide and interaction asserted in DrugBank between Acetaminophen and Magnesium oxide.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> valACYclovir 1 GM Oral Tablet
Drug1 (rxcui = 209468, name = acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin], tty = SBD). Drug2 (rxcui = 313564, name = valacyclovir 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to valacyclovir and interaction asserted in DrugBank between Acetaminophen and Valaciclovir. Drug1 is resolved to aspirin, Drug2 is resolved to valacyclovir and interaction asserted in DrugBank between Acetylsalicylic acid and Valaciclovir.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> Depakote 125 MG Delayed Release Oral Tablet
Drug1 (rxcui = 866924, name = metoprolol tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099626, name = divalproex sodium 125 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to metoprolol, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Metoprolol and Valproic acid. Drug1 is resolved to metoprolol, Drug2 is resolved to valproate and interaction asserted in DrugBank between Metoprolol and Valproic acid.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
Drug1 (rxcui = 209468, name = acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin], tty = SBD). Drug2 (rxcui = 866924, name = metoprolol tartrate 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to caffeine, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Caffeine and Metoprolol. Drug1 is resolved to aspirin, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Acetylsalicylic acid and Metoprolol. Drug1 is resolved to acetaminophen, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Acetaminophen and Metoprolol.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> atorvastatin 20 MG Oral Tablet
Drug1 (rxcui = 209468, name = acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin], tty = SBD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Acetaminophen and Atorvastatin.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Depakote 125 MG Delayed Release Oral Tablet
Drug1 (rxcui = 209468, name = acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin], tty = SBD). Drug2 (rxcui = 1099626, name = divalproex sodium 125 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to aspirin, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Acetylsalicylic acid and Valproic acid. Drug1 is resolved to acetaminophen, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Acetaminophen and Valproic acid. Drug1 is resolved to caffeine, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Caffeine and Valproic acid. Drug1 is resolved to acetaminophen, Drug2 is resolved to valproate and interaction asserted in DrugBank between Acetaminophen and Valproic acid. Drug1 is resolved to aspirin, Drug2 is resolved to valproate and interaction asserted in DrugBank between Acetylsalicylic acid and Valproic acid. Drug1 is resolved to caffeine, Drug2 is resolved to valproate and interaction asserted in DrugBank between Caffeine and Valproic acid.
Applies to: Magnesium Oxide 400 MG Oral Tablet <> Levothyroxine Sodium 0.15 MG Oral Tablet
Drug1 (rxcui = 198741, name = magnesium oxide 400 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to magnesium oxide, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Magnesium oxide and Levothyroxine.
Applies to: Levothyroxine Sodium 0.15 MG Oral Tablet <> atorvastatin 20 MG Oral Tablet
Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Levothyroxine and Atorvastatin.
Applies to: Depakote 125 MG Delayed Release Oral Tablet <> atorvastatin 20 MG Oral Tablet
Drug1 (rxcui = 1099626, name = divalproex sodium 125 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Valproic acid and Atorvastatin. Drug1 is resolved to valproic acid, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Valproic acid and Atorvastatin.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> Levothyroxine Sodium 0.15 MG Oral Tablet
Drug1 (rxcui = 866924, name = metoprolol tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Metoprolol and Levothyroxine.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> valACYclovir 1 GM Oral Tablet
Drug1 (rxcui = 866924, name = metoprolol tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 313564, name = valacyclovir 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to valacyclovir and interaction asserted in DrugBank between Metoprolol and Valaciclovir.
Applies to: Depakote 125 MG Delayed Release Oral Tablet <> valACYclovir 1 GM Oral Tablet
Drug1 (rxcui = 1099626, name = divalproex sodium 125 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug2 (rxcui = 313564, name = valacyclovir 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to valacyclovir and interaction asserted in DrugBank between Valproic acid and Valaciclovir. Drug1 is resolved to valproic acid, Drug2 is resolved to valacyclovir and interaction asserted in DrugBank between Valproic acid and Valaciclovir.
Applies to: Levothyroxine Sodium 0.15 MG Oral Tablet <> Depakote 125 MG Delayed Release Oral Tablet
Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099626, name = divalproex sodium 125 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to levothyroxine, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levothyroxine and Valproic acid. Drug1 is resolved to levothyroxine, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levothyroxine and Valproic acid.
Applies to: Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet <> Levothyroxine Sodium 0.15 MG Oral Tablet
Drug1 (rxcui = 209468, name = acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin], tty = SBD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to caffeine, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Caffeine and Levothyroxine. Drug1 is resolved to aspirin, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Acetylsalicylic acid and Levothyroxine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.